BACKGROUND: Carcinogenic human papillomaviruses (HPVs) cause a large proportion of anal cancers. Human immunodeficiency virus (HIV)-infected men who have sex with men (MSM) are at increased risk of HPV infection and anal cancer compared with HIV-negative men. We evaluated risk factors for HPV infection and anal precancer in a population of HIV-infected MSM. METHODS: Our study included 305 MSM at an HIV/AIDS clinic in the Kaiser Permanente Northern California Health Maintenance Organization. Logistic regression was used to estimate associations of risk factors comparing men without anal HPV infection; men with anal HPV infection, but no precancer; and men with anal precancer. RESULTS: Low CD4 count (<350 cells/mm(3)) and previous chlamydia infection were associated with an increased risk of carcinogenic HPV infection (odds ratio [OR], 3.65; 95% confidence interval [CI], 1.28-10.40 and OR, 4.24; 95% CI, 1.16-15.51, respectively). History of smoking (OR, 2.71 95% CI, 1.43-5.14), duration, recency, and dose of smoking increased the risk of anal precancer among carcinogenic HPV-positive men but had no association with HPV infection. CONCLUSIONS: We found distinct risk factors for anal HPV infection and anal precancer. Risk factors for HPV infection and anal precancer are similar to established risk factors for cervical cancer progression.
BACKGROUND:Carcinogenic human papillomaviruses (HPVs) cause a large proportion of anal cancers. Human immunodeficiency virus (HIV)-infectedmen who have sex with men (MSM) are at increased risk of HPV infection and anal cancer compared with HIV-negative men. We evaluated risk factors for HPV infection and anal precancer in a population of HIV-infected MSM. METHODS: Our study included 305 MSM at an HIV/AIDS clinic in the Kaiser Permanente Northern California Health Maintenance Organization. Logistic regression was used to estimate associations of risk factors comparing men without anal HPV infection; men with anal HPV infection, but no precancer; and men with anal precancer. RESULTS: Low CD4 count (<350 cells/mm(3)) and previous chlamydia infection were associated with an increased risk of carcinogenic HPV infection (odds ratio [OR], 3.65; 95% confidence interval [CI], 1.28-10.40 and OR, 4.24; 95% CI, 1.16-15.51, respectively). History of smoking (OR, 2.71 95% CI, 1.43-5.14), duration, recency, and dose of smoking increased the risk of anal precancer among carcinogenic HPV-positivemen but had no association with HPV infection. CONCLUSIONS: We found distinct risk factors for anal HPV infection and anal precancer. Risk factors for HPV infection and anal precancer are similar to established risk factors for cervical cancer progression.
Entities:
Keywords:
anal cancer; anal intraepithelial neoplasia (AIN); human immunodeficiency virus (HIV); human papillomavirus (HPV); men who have sex with men (MSM)
Authors: Isabella Rosa-Cunha; Vincent A Degennaro; Rene Hartmann; Clara Milikowski; Andres Irizarry; Brenda Heitman; Orlando Gómez-Marín; Gordon M Dickinson Journal: AIDS Patient Care STDS Date: 2011-03-02 Impact factor: 5.078
Authors: Teresa M Darragh; Diane Tokugawa; Philip E Castle; Stephen Follansbee; Sylvia Borgonovo; Brandon J LaMere; Lauren Schwartz; Julia C Gage; Barbara Fetterman; Thomas Lorey; Nicolas Wentzensen Journal: Cancer Cytopathol Date: 2012-07-18 Impact factor: 5.284
Authors: Peter V Chin-Hong; Eric Vittinghoff; Ross D Cranston; Lynette Browne; Susan Buchbinder; Grant Colfax; Maria Da Costa; Teresa Darragh; Dana Jones Benet; Franklyn Judson; Beryl Koblin; Kenneth H Mayer; Joel M Palefsky Journal: J Natl Cancer Inst Date: 2005-06-15 Impact factor: 13.506
Authors: Alan G Nyitray; Roberto J Carvalho da Silva; Maria Luiza Baggio; Dan'elle Smith; Martha Abrahamsen; Mary Papenfuss; Hui-Yi Lin; Manuel Quiterio; Jorge Salmerón; Eduardo Lazcano-Ponce; Luisa L Villa; Anna R Giuliano Journal: J Infect Dis Date: 2011-09-30 Impact factor: 5.226
Authors: Roswell Quinn; Javier Salvatierra; Vicky Solari; Martha Calderon; Thanh G N Ton; Joseph R Zunt Journal: AIDS Res Hum Retroviruses Date: 2012-06-01 Impact factor: 2.205
Authors: Sophia S Wang; Rosemary E Zuna; Nicolas Wentzensen; S Terence Dunn; Mark E Sherman; Michael A Gold; Mark Schiffman; Sholom Wacholder; Richard A Allen; Ingrid Block; Kim Downing; Jose Jeronimo; J Daniel Carreon; Mahboobeh Safaeian; David Brown; Joan L Walker Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-01 Impact factor: 4.254
Authors: Hugo De Vuyst; Gary M Clifford; Maria Claudia Nascimento; Margaret M Madeleine; Silvia Franceschi Journal: Int J Cancer Date: 2009-04-01 Impact factor: 7.396
Authors: Lesley S Park; Raúl U Hernández-Ramírez; Michael J Silverberg; Kristina Crothers; Robert Dubrow Journal: AIDS Date: 2016-01 Impact factor: 4.177
Authors: Sean F Altekruse; Meredith S Shiels; Sharada P Modur; Stephanie R Land; Kristina A Crothers; Mari M Kitahata; Jennifer E Thorne; William C Mathews; Diana M Fernández-Santos; Angel M Mayor; John M Gill; Michael A Horberg; John T Brooks; Richard D Moore; Michael J Silverberg; Keri N Althoff; Eric A Engels Journal: AIDS Date: 2018-02-20 Impact factor: 4.177
Authors: Kandyce Keller; Jeslie M Ramos-Cartagena; Humberto M Guiot; Cristina Muñoz; Yolanda Rodríguez; Vivian Colón-López; Ashish A Deshmukh; Maribel Tirado-Gómez; Ana Patricia Ortiz Journal: Cancer Treat Res Commun Date: 2021-12-31
Authors: Nicolas Wentzensen; Stephen Follansbee; Sylvia Borgonovo; Diane Tokugawa; Vikrant V Sahasrabuddhe; Jie Chen; Thomas S Lorey; Julia C Gage; Barbara Fetterman; Sean Boyle; Mark Sadorra; Scott Dahai Tang; Teresa M Darragh; Philip E Castle Journal: J Clin Microbiol Date: 2014-06-04 Impact factor: 5.948
Authors: A L Wirtz; C E Zelaya; A Peryshkina; I McGowan; R D Cranston; C Latkin; N Galai; V Mogilniy; P Dzhigun; I Kostetskaya; C Beyrer Journal: Euro Surveill Date: 2015-04-16